An analysis of hospital data in Tunisia found that subtype 2 (papulopustular) rosacea, characterized by redness with bumps and pimples, was the most commonly diagnosed form of rosacea in this Arab North African nation.1
While some signs and symptoms of rosacea can be challenging to control, effective medical therapies have been extensively studied and approved for the treatment of the bumps and pimples of subtype 2 (papulopustular) rosacea, according to the standard management options for rosacea recently published by the National Rosacea Society.1
The National Rosacea Society (NRS) has awarded funding for four new studies as part of its research grants program to advance scientific knowledge of the potential causes and other key aspects of this chronic and potentially life-disruptive disorder that affects an estimated 14 million Americans.
The bumps (papules) and pimples (pustules) of rosacea, a widespread facial disorder affecting an estimated 14 million Americans, in some instances may be the result of an allergy-like reaction to environmental and emotional triggers, according to new study results presented at the National Rosacea Society (NRS) research workshop during the annual meeting of the Society for Investigative Dermatology. The seventh annual NRS workshop was attended by more than 130 medical scientists from around the world.
The incidence of rosacea may be higher than widely believed, according to a preliminary study presented at the recent rosacea research workshop, sponsored by the National Rosacea Society (NRS) during the annual Society for Investigative Dermatology meeting. In addition, an ongoing Irish study found similar prevalence rates of subtype 2 (papulopustular) rosacea in both indoor and outdoor workers.
Five new studies of rosacea have been awarded funding as part of the National Rosacea Society's research grants program to advance scientific and medical understanding of this widespread but poorly understood facial disorder, estimated to affect 14 million Americans.